Fertility in male patients with Hodgkin's disease - Results from the German Hodgkin Lymphoma Study Group (GHSG).

被引：0
|
作者：
Sieniawski, M [1 ]
Josting, A [1 ]
Breuer, K [1 ]
Diehl, V [1 ]
Engert, A [1 ]
机构：
[1] Univ Hosp Cologne, Clin Intermal Med 1, Cologne, Germany
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1315
引用
收藏
页码：370A / 370A
页数：1
相关论文
共 50 条
  • [21] Secondary malignancies after primary Hodgkin's disease: Incidence, treatment and prognosis - A report from the German Hodgkin's lymphoma study group (GHSG)
    Engert, A
    Josting, A
    Wingbermuehle, K
    Behringer, K
    Brillant, C
    Pfistner, B
    Sieber, M
    Rueffer, U
    Franklin, J
    Wolf, J
    Mueller, RP
    Diehl, V
    BLOOD, 2002, 100 (11) : 280B - 280B
  • [22] Symptomatic osteonecrosis as a treatment complication in Hodgkin lymphoma: an analysis of the German Hodgkin Study Group (GHSG)
    Sven Borchmann
    Horst Müller
    Heinz Haverkamp
    Christian Baues
    Jana Marková
    Andreas Hüttmann
    Axel Glunz
    Michael Fuchs
    Peter Borchmann
    Andreas Engert
    Leukemia, 2019, 33 : 439 - 446
  • [23] Symptomatic osteonecrosis as a treatment complication in Hodgkin lymphoma: an analysis of the German Hodgkin Study Group (GHSG)
    Borchmann, Sven
    Mueller, Horst
    Haverkamp, Heinz
    Baues, Christian
    Markova, Jana
    Huettmann, Andreas
    Glunz, Axel
    Fuchs, Michael
    Borchmann, Peter
    Engert, Andreas
    LEUKEMIA, 2019, 33 (02) : 439 - 446
  • [24] Relapsed Nodular Lymphocyte-Predominant Hodgkin Lymphoma: An Analysis from the German Hodgkin Study Group (GHSG)
    Eichenauer, Dennis A.
    Pluetschow, Annette
    Schroeder, Lena
    Fuchs, Michael
    von Tresckow, Bastian
    Diehl, Volker
    Borchmann, Peter
    Engert, Andreas
    BLOOD, 2016, 128 (22)
  • [25] Clinical outcomes of relapsed Hodgkin lymphoma patients after contemporary first-line treatment: Results from the German Hodgkin Study Group (GHSG)
    Brockelmann, P.
    Muller, H.
    Gillessen, S.
    Yang, X.
    Koppel, L.
    Pilz, V
    Marinello, P.
    Kaskel, P.
    Raut, M.
    Fuchs, M.
    Borchmann, P.
    Engert, A.
    von Tresckow, B.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 37 - 37
  • [26] Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin lymphoma study group
    Behringer, K
    Josting, A
    Schiller, P
    Eich, HT
    Bredenfeld, H
    Diehl, V
    Engert, A
    ANNALS OF ONCOLOGY, 2004, 15 (07) : 1079 - 1085
  • [27] Treatment-related mortality in patients undergoing therapy for advanced Hodgkin's Lymphoma: Analysis of the German Hodgkin Study Group (GHSG)
    Wongso, D.
    Pluetschow, A.
    Fuchs, M.
    Haverkamp, H.
    Klimm, B.
    Sasse, S.
    Diehl, V
    Borchmann, P.
    Engert, A.
    ONKOLOGIE, 2012, 35 : 169 - 170
  • [28] TREATMENT-RELATED MORTALITY IN PATIENTS UNDERGOING THERAPY FOR ADVANCED HODGKIN'S LYMPHOMA: ANALYSIS OF THE GERMAN HODGKIN STUDY GROUP (GHSG)
    Wongso, D.
    Pluetschow, A.
    Fuchs, M.
    Haverkamp, H.
    Klimm, B.
    Sasse, S.
    Diehl, V.
    Engert, A.
    Borchmann, P.
    HAEMATOLOGICA, 2012, 97 : 457 - 457
  • [29] Rituximab in relapsed lymphocyte predominant Hodgkin's disease (LPHD). Long-term results of a phase-II study from the German Hodgkin Lymphoma Study Group (GHSG).
    Schulz, H
    Trelle, S
    Reiser, M
    Sieber, M
    Diehl, V
    Engert, A
    BLOOD, 2005, 106 (11) : 433A - 433A
  • [30] The role of dose intensity for advanced stage Hodgkin's Disease - Studies of the German Hodgkin study group (GHSG)
    Tesch, H
    Lathan, B
    Hasenclever, D
    Ruffer, U
    Sieber, M
    Engert, A
    Pfreundschuh, M
    Koch, P
    Adler, M
    Muller, U
    Schalk, P
    Dolken, G
    Worst, P
    Boissevain, F
    Loffler, M
    Diehl, V
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1408 - 1408
12345